|
Jacob DreyerThe New York Times |
Different strokes for different folks.
China no longer looks to an erratic America as a model to emulate, but as a distraction to be managed.
China’s biotechnology sector has established a bright future by focusing not on breakthrough cures and treatments but on speed and efficiency.
In the great dance between the two rivals, it’s getting harder to tell which of them is leading and which is following.